Correction: Kazia is commencing a GBM agile phase TWO trial sometime next year. NOT a phase 3 trial. The sequential phase three trial completion is two to three years away and it will only start if the P2 is successful completed. By that time the better performing competitors drug has a good chance of being up and running. That will be good news for patients As always this is my opinion and not advice
KZA Price at posting:
$1.37 Sentiment: None Disclosure: Not Held
